Voloridge Investment Management’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-92,517
Closed -$9.93M 1285
2024
Q1
$9.93M Sell
92,517
-25,522
-22% -$2.54M 0.04% 493
2023
Q4
$11.8M Buy
+118,039
New +$11.5M 0.05% 439
2021
Q4
Sell
-15,021
Closed -$3.51M 1691
2021
Q3
$3.51M Buy
15,021
+10,957
+270% +$2.3M 0.02% 829
2021
Q2
$836K Buy
+4,064
New +$836K 0.01% 1310
2021
Q1
Sell
-2,412
Closed -$517K 1518
2020
Q4
$517K Sell
2,412
-20,918
-90% -$4.06M ﹤0.01% 1115
2020
Q3
$4.26M Buy
23,330
+5,863
+34% +$1.1M 0.04% 489
2020
Q2
$3.22M Buy
+17,467
New +$3.47M 0.04% 469
2019
Q4
Sell
-14,162
Closed -$2.26M 1212
2019
Q3
$2.26M Buy
+14,162
New +$2.82M 0.04% 418
2018
Q3
Sell
-14,337
Closed -$4.21M 375
2018
Q2
$4.21M Buy
14,337
+4,973
+53% +$1.36M 0.11% 183
2018
Q1
$2.36M Buy
9,364
+8,358
+831% +$1.96M 0.06% 265
2017
Q4
$217K Buy
+1,006
New +$204K ﹤0.01% 462
2017
Q3
Sell
-4,334
Closed -$748K 448
2017
Q2
$748K Buy
+4,334
New +$695K 0.02% 338
2017
Q1
Sell
-5,081
Closed -$749K 575
2016
Q4
$749K Buy
+5,081
New +$735K 0.02% 517

Other funds holding ICUI

Voloridge Investment Management's ICUI Position: Q2 2024 in Review

Voloridge Investment Management sold out of ICU Medical (ICUI) in Q2 2024, closing a stake of 92,517 shares — an estimated $9.93M sold.

Voloridge Investment Management first reported a position in ICUI in Q4 2016 and held it in 13 quarters. The position peaked at $11.8M in Q4 2023. 255 funds tracked by Wall St. Rank hold ICUI as of Q2 2024.

  • Voloridge Investment Management reported no remaining ICU Medical position as of Q2 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 92,517 ICU Medical shares in Q2 2024, an estimated $9.93M.
  • Voloridge Investment Management first reported a position in ICU Medical in Q4 2016 and held it in 13 quarters.
  • Voloridge Investment Management's ICU Medical position peaked at $11.8M in Q4 2023.
  • 255 funds tracked by Wall St. Rank held ICU Medical as of Q2 2024.

Based on Voloridge Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.